Cargando…

Tumor Induced Hepatic Myeloid Derived Suppressor Cells Can Cause Moderate Liver Damage

Subcutaneous tumors induce the accumulation of myeloid derived suppressor cells (MDSC) not only in blood and spleens, but also in livers of these animals. Unexpectedly, we observed a moderate increase in serum transaminases in mice with EL4 subcutaneous tumors, which prompted us to study the relatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eggert, Tobias, Medina-Echeverz, José, Kapanadze, Tamar, Kruhlak, Michael J., Korangy, Firouzeh, Greten, Tim F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234460/ https://www.ncbi.nlm.nih.gov/pubmed/25401795 http://dx.doi.org/10.1371/journal.pone.0112717

Ejemplares similares

Hepatic myeloid-derived suppressor cells in tumor bearing mice exacerbate hepatitis and transform into pro-inflammatory myeloid cells
por: Medina-Echeverz, Jose, et al.
Publicado: (2013)

Dipeptidyl peptidase 3 and thimet oligopeptidase 1 knockdown support tumor-specific immune responses to whole cell cancer vaccines and tumor cell death in vivo
por: Gamrekelashvili, Jaba, et al.
Publicado: (2013)

Agonistic CD40 antibody induces immune-mediated liver damage and modulates tumor-induced myeloid suppressive cells
por: Medina-Echeverz, Jose, et al.
Publicado: (2014)

Human Th17 cells in patients with cancer: Friends or foe?
por: Greten, Tim F., et al.
Publicado: (2012)

Tumour-Associated Transcripts and EGFR Deletion Variants in Colorectal Cancer in Primary Tumour, Metastases and Circulating Tumour Cells
por: Lankiewicz, Silke, et al.
Publicado: (2008)

Immune studies in a mouse model of MET and CAT induced liver tumors
por: Eggert, Tobias, et al.
Publicado: (2014)

Primary sterile necrotic cells fail to cross-prime CD8(+) T cells
por: Gamrekelashvili, Jaba, et al.
Publicado: (2012)

Plasticity of Innate Lymphoid Cells in Cancer
por: Heinrich, Bernd, et al.
Publicado: (2022)

Myeloid-derived cells are key targets of tumor immunotherapy
por: Medina-Echeverz, José, et al.
Publicado: (2014)

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
por: Greten, Tim F, et al.
Publicado: (2010)

Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma
por: Heinrich, Bernd, et al.
Publicado: (2022)

Molecular therapy for the treatment of hepatocellular carcinoma
por: Greten, T F, et al.
Publicado: (2009)

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
por: Bronte, Vincenzo, et al.
Publicado: (2016)

NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis
por: Ma, Chi, et al.
Publicado: (2016)

Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells
por: Pallett, Laura J., et al.
Publicado: (2015)

Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences
por: Pillay, Janesh, et al.
Publicado: (2013)

Myeloid-Derived Suppressor Cells in Lung Transplantation
por: Heigl, Tobias, et al.
Publicado: (2019)

Hepatic RACK1 deficiency protects against fulminant hepatitis through myeloid-derived suppressor cells
por: Liu, Genyu, et al.
Publicado: (2022)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

Expansion of Granulocytic, Myeloid-Derived Suppressor Cells in Response to Ethanol-Induced Acute Liver Damage
por: Li, Sha, et al.
Publicado: (2018)

The protective role of myeloid-derived suppressor cells in concanavalin A-induced hepatic injury
por: Diao, Wenli, et al.
Publicado: (2014)

Canonical NF-κB signaling in myeloid cells promotes lung metastasis in a mouse breast cancer model
por: Neumann, Tobias, et al.
Publicado: (2018)

Myeloid-Derived Suppressor Cells in Sepsis
por: Lai, Dengming, et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells in Sepsis
por: Schrijver, Irene T., et al.
Publicado: (2019)

On the origin of myeloid-derived suppressor cells
por: Millrud, Camilla Rydberg, et al.
Publicado: (2016)

Myeloid-derived suppressor cells in gliomas
por: Gieryng, Anna, et al.
Publicado: (2016)

Cinnamaldehyde causes apoptosis of myeloid-derived suppressor cells through the activation of TLR4
por: He, Wanzhuo, et al.
Publicado: (2019)

Systematic evaluation of immune regulation and modulation
por: Stroncek, David F., et al.
Publicado: (2017)

Tpl2 Protects Against Fulminant Hepatitis Through Mobilization of Myeloid-Derived Suppressor Cells
por: Xu, Jing, et al.
Publicado: (2019)

Inhibition of Dot1L Alleviates Fulminant Hepatitis Through Myeloid-Derived Suppressor Cells
por: Yang, Wanlin, et al.
Publicado: (2021)

Hierarchical Involvement of Myeloid-Derived Suppressor Cells and Monocytes Expressing Latency-Associated Peptide in Plasma Cell Dyscrasias
por: Tadmor, Tamar, et al.
Publicado: (2018)

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
por: Veglia, Filippo, et al.
Publicado: (2021)

Myeloid derived suppressor cells: Targets for therapy
por: Waldron, Todd J., et al.
Publicado: (2013)

Myeloid-derived suppressor cells, age and cancer
por: Bowdish, Dawn ME
Publicado: (2013)

Chemotherapeutic targeting of myeloid-derived suppressor cells
por: Alizadeh, Darya, et al.
Publicado: (2014)

Myeloid Derived Suppressor Cells: Fuel the Fire
por: Achyut, B. R., et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells in Bacterial Infections
por: Ost, Michael, et al.
Publicado: (2016)

Myeloid-Derived Suppressor Cells and Pulmonary Hypertension
por: Bryant, Andrew J., et al.
Publicado: (2018)

The Yin and Yang of Myeloid Derived Suppressor Cells
por: Budhwar, Snehil, et al.
Publicado: (2018)

In Brief: Myeloid‐derived suppressor cells in cancer
por: Solito, S, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7lhkbsihvbo0rb8tagd899a6rs